ArticleClinical drug investigation2022

Combination of Bevacizumab and Osimertinib in Patients with EGFR T790M-Mutated Non-small Cell Lung Cancer.

Sha Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.